-
1
-
-
84883231183
-
-
NIDA Info Facts. National Institute on Drug Abuse, Bethesda, MD. Available online at.
-
NIDA Info Facts (2010) Cocaine. National Institute on Drug Abuse, Bethesda, MD. Available online at www.drugabuse.gov/publications/drugfacts/ cocaine.
-
(2010)
Cocaine
-
-
-
2
-
-
79953874957
-
-
NIDA Research Report Series. National Institute on Drug Abuse, Bethesda, MD. Available online at.
-
NIDA Research Report Series (2009) Cocaine: abuse and addiction. National Institute on Drug Abuse, Bethesda, MD. Available online at www.drugabuse.gov/ publications/research-reports/cocaine-abuse-addiction.
-
(2009)
Cocaine: Abuse and Addiction
-
-
-
3
-
-
63249098863
-
Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry
-
Kalivas, P. W. (2008) Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry Neurotoxic. Res. 14, 185-189
-
(2008)
Neurotoxic. Res.
, vol.14
, pp. 185-189
-
-
Kalivas, P.W.1
-
4
-
-
0032834028
-
Pharmacological agents acting at subtypes of metabotropic glutamate receptors
-
Schoepp, D. D., Jane, D. E., and Monn, J. A. (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors Neuropharmacology 38, 1431-1476
-
(1999)
Neuropharmacology
, vol.38
, pp. 1431-1476
-
-
Schoepp, D.D.1
Jane, D.E.2
Monn, J.A.3
-
5
-
-
0030995878
-
Pharmacology and functions of metabotropic glutamate receptors
-
Conn, P. J. and Pin, J.-P. (1997) Pharmacology and functions of metabotropic glutamate receptors Annu. Rev. Pharmacol. Toxicol. 37, 205-237
-
(1997)
Annu. Rev. Pharmacol. Toxicol.
, vol.37
, pp. 205-237
-
-
Conn, P.J.1
Pin, J.-P.2
-
6
-
-
84857375139
-
Allosteric modulation of seven transmembrane spanning receptors: Theory, practice, and opportunities for central nervous system drug discovery
-
Melancon, B. J., Hopkins, C. R., Wood, M. R., Emmitte, K. A., Niswender, C. M., Christopoulos, A., Conn, P. J., and Lindsley, C. W. (2012) Allosteric modulation of seven transmembrane spanning receptors: Theory, practice, and opportunities for central nervous system drug discovery J. Med. Chem. 55, 1445-1464
-
(2012)
J. Med. Chem.
, vol.55
, pp. 1445-1464
-
-
Melancon, B.J.1
Hopkins, C.R.2
Wood, M.R.3
Emmitte, K.A.4
Niswender, C.M.5
Christopoulos, A.6
Conn, P.J.7
Lindsley, C.W.8
-
7
-
-
58149193205
-
Allosteric modulators of GPCRs as a novel approach to treatment of CNS disorders
-
Conn, P. J., Christopolous, A., and Lindsley, C. W. (2009) Allosteric modulators of GPCRs as a novel approach to treatment of CNS disorders Nat. Rev. Drug Discovery 8, 41-54
-
(2009)
Nat. Rev. Drug Discovery
, vol.8
, pp. 41-54
-
-
Conn, P.J.1
Christopolous, A.2
Lindsley, C.W.3
-
8
-
-
53449093828
-
G-protein coupled receptors: From classical modes of modulation to allosteric mechanisms
-
Bridges, T. M. and Lindsley, C. W. (2008) G-protein coupled receptors: From classical modes of modulation to allosteric mechanisms ACS Chem. Biol. 3, 530-542
-
(2008)
ACS Chem. Biol.
, vol.3
, pp. 530-542
-
-
Bridges, T.M.1
Lindsley, C.W.2
-
9
-
-
26444616159
-
Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators
-
Ritzén, A., Mathiesen, J. M., and Thomsen, C. (2005) Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators Basic Clin. Pharmacol. Toxicol. 97, 202-213
-
(2005)
Basic Clin. Pharmacol. Toxicol.
, vol.97
, pp. 202-213
-
-
Ritzén, A.1
Mathiesen, J.M.2
Thomsen, C.3
-
10
-
-
84875192840
-
5 negative allosteric modulators: A patent review (2010-2012)
-
5 negative allosteric modulators: a patent review (2010-2012) Expert Opin. Ther. Pat. 23, 393-408
-
(2013)
Expert Opin. Ther. Pat.
, vol.23
, pp. 393-408
-
-
Emmitte, K.A.1
-
12
-
-
79952936972
-
MGluR5 negative allosteric modulators overview: A medicinal chemistry approach towards a series of novel therapeutics
-
Rocher, J. P., Bonnet, B., Boléa, C., Lütjens, R., Le Poul, E., Poli, S., Epping-Jordan, M., Bessis, A.-S., Ludwig, B., and Mutel, V. (2011) mGluR5 negative allosteric modulators overview: A medicinal chemistry approach towards a series of novel therapeutics Curr. Top. Med. Chem. 11, 680-695
-
(2011)
Curr. Top. Med. Chem.
, vol.11
, pp. 680-695
-
-
Rocher, J.P.1
Bonnet, B.2
Boléa, C.3
Lütjens, R.4
Le Poul, E.5
Poli, S.6
Epping-Jordan, M.7
Bessis, A.-S.8
Ludwig, B.9
Mutel, V.10
-
13
-
-
67649992440
-
Recent progress in the discovery and development of negative allosteric modulators of mGluR5
-
Lindsley, C. W. and Emmitte, K. A. (2009) Recent progress in the discovery and development of negative allosteric modulators of mGluR5 Curr. Opin. Drug Discovery Dev. 12, 446-457
-
(2009)
Curr. Opin. Drug Discovery Dev.
, vol.12
, pp. 446-457
-
-
Lindsley, C.W.1
Emmitte, K.A.2
-
14
-
-
50249155962
-
MGluR5 antagonists: Discovery, characterization and drug development
-
Gasparini, F., Bilbe, G., Gomez-Mancilla, B., and Spooren, W. (2008) mGluR5 antagonists: Discovery, characterization and drug development Curr. Opin. Drug Discovery Dev. 11, 655-665
-
(2008)
Curr. Opin. Drug Discovery Dev.
, vol.11
, pp. 655-665
-
-
Gasparini, F.1
Bilbe, G.2
Gomez-Mancilla, B.3
Spooren, W.4
-
15
-
-
84883252481
-
-
Based on searches performed at on 19 February.
-
Based on searches performed at www.clinicaltrials.gov on 19 February, 2013.
-
(2013)
-
-
-
16
-
-
17744400697
-
Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats
-
Kenny, P. J., Boutrel, B., Gasparini, F., Koob, G. F., and Markou, A. (2005) Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats Psychopharmacology 179, 247-254
-
(2005)
Psychopharmacology
, vol.179
, pp. 247-254
-
-
Kenny, P.J.1
Boutrel, B.2
Gasparini, F.3
Koob, G.F.4
Markou, A.5
-
17
-
-
0034867765
-
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
-
Chiamulera, C., Epping-Jordan, M. P., Zocchi, A., Marcon, C., Cottiny, C., Tacconi, S., Corsi, M., Orzi, F., and Conquet, F. (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice Nat. Neurosci. 4, 873-874
-
(2001)
Nat. Neurosci.
, vol.4
, pp. 873-874
-
-
Chiamulera, C.1
Epping-Jordan, M.P.2
Zocchi, A.3
Marcon, C.4
Cottiny, C.5
Tacconi, S.6
Corsi, M.7
Orzi, F.8
Conquet, F.9
-
18
-
-
0032853255
-
Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systematically active mGlu5 receptor antagonist
-
Gasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P. J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendorn, R., Urwyler, S., Varney, M. A., Johnson, E. C., Hess, S. D., Rao, S. P., Sacaan, A. I., Santori, E. M., Veliocelebi, G., and Kuhn, R. (1999) Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systematically active mGlu5 receptor antagonist Neuropharmacology 38, 1493-1503
-
(1999)
Neuropharmacology
, vol.38
, pp. 1493-1503
-
-
Gasparini, F.1
Lingenhöhl, K.2
Stoehr, N.3
Flor, P.J.4
Heinrich, M.5
Vranesic, I.6
Biollaz, M.7
Allgeier, H.8
Heckendorn, R.9
Urwyler, S.10
Varney, M.A.11
Johnson, E.C.12
Hess, S.D.13
Rao, S.P.14
Sacaan, A.I.15
Santori, E.M.16
Veliocelebi, G.17
Kuhn, R.18
-
19
-
-
0037448394
-
3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: A potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity
-
Cosford, N. D., Tehrani, L., Roppe, J., Schweiger, E., Smith, N. D., Anderson, J., Bristow, L., Brodkin, J., Jiang, X., McDonald, I., Rao, S., Washburn, M., and Varney, M. A. (2003) 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity J. Med. Chem. 46, 204-206
-
(2003)
J. Med. Chem.
, vol.46
, pp. 204-206
-
-
Cosford, N.D.1
Tehrani, L.2
Roppe, J.3
Schweiger, E.4
Smith, N.D.5
Anderson, J.6
Bristow, L.7
Brodkin, J.8
Jiang, X.9
McDonald, I.10
Rao, S.11
Washburn, M.12
Varney, M.A.13
-
20
-
-
65549145853
-
Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking
-
Kumaresan, V., Yuan, M., Yee, J., Famous, K. R., Anderson, S. M., Schmidt, H. D., and Pierce, R. C. (2009) Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking Behav. Brain Res. 202, 238-244
-
(2009)
Behav. Brain Res.
, vol.202
, pp. 238-244
-
-
Kumaresan, V.1
Yuan, M.2
Yee, J.3
Famous, K.R.4
Anderson, S.M.5
Schmidt, H.D.6
Pierce, R.C.7
-
21
-
-
51249102144
-
Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: Comparison with dizocilpine
-
Platt, D. M., Rowlett, J. K., and Spealman, R. D. (2008) Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine Psychopharmacology 200, 167-176
-
(2008)
Psychopharmacology
, vol.200
, pp. 167-176
-
-
Platt, D.M.1
Rowlett, J.K.2
Spealman, R.D.3
-
22
-
-
14344261021
-
Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: Comparison with dizocilpine
-
Lee, B., Platt, D. M., Rowlett, J. K., Adewale, A. S., and Spealman, R. D. (2005) Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine J. Pharmacol. Exp. Ther. 312, 1232-1240
-
(2005)
J. Pharmacol. Exp. Ther.
, vol.312
, pp. 1232-1240
-
-
Lee, B.1
Platt, D.M.2
Rowlett, J.K.3
Adewale, A.S.4
Spealman, R.D.5
-
23
-
-
19244387486
-
Antagonism at metabotropic glutamate 5 receptor inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking
-
Tessari, M., Pilla, M., Andreoli, M., Hutcheson, D. M., and Heidbreder, C. A. (2004) Antagonism at metabotropic glutamate 5 receptor inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking Eur. J. Pharmacol. 499, 121-133
-
(2004)
Eur. J. Pharmacol.
, vol.499
, pp. 121-133
-
-
Tessari, M.1
Pilla, M.2
Andreoli, M.3
Hutcheson, D.M.4
Heidbreder, C.A.5
-
24
-
-
0037337238
-
The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse
-
McGeehan, A. J. and Olive, M. F. (2003) The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse Synapse 47, 240-242
-
(2003)
Synapse
, vol.47
, pp. 240-242
-
-
McGeehan, A.J.1
Olive, M.F.2
-
25
-
-
84871791218
-
Role of mGluR5 neurotransmission in reinstated cocaine-seeking
-
Wang, X., Moussawi, K., Knackstedt, L., Shen, H., and Kalivas, P. W. (2013) Role of mGluR5 neurotransmission in reinstated cocaine-seeking Addict. Biol. 18, 40-49
-
(2013)
Addict. Biol.
, vol.18
, pp. 40-49
-
-
Wang, X.1
Moussawi, K.2
Knackstedt, L.3
Shen, H.4
Kalivas, P.W.5
-
26
-
-
66749130963
-
Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]pyridine] on conditioned reinstatement and reinforcement: Comparison between cocaine and a conventional reinforcer
-
Martin-Fardon, R., Baptista, M. A. S., Dayas, C. V., and Weiss, F. (2009) Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl] pyridine] on conditioned reinstatement and reinforcement: Comparison between cocaine and a conventional reinforcer J. Pharmacol. Exp. Ther. 329, 1084-1090
-
(2009)
J. Pharmacol. Exp. Ther.
, vol.329
, pp. 1084-1090
-
-
Martin-Fardon, R.1
Baptista, M.A.S.2
Dayas, C.V.3
Weiss, F.4
-
27
-
-
33645025726
-
Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking
-
Bäckstrom, P. and Hyytiä, P. (2006) Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking Neuropsychopharmacology 31, 778-786
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 778-786
-
-
Bäckstrom, P.1
Hyytiä, P.2
-
28
-
-
78649785280
-
Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5)
-
Olsen, C. M., Childs, D. S., Stanwood, G. D., and Winder, D. G. (2010) Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5) PLoS One 5, e15085
-
(2010)
PLoS One
, vol.5
, pp. 15085
-
-
Olsen, C.M.1
Childs, D.S.2
Stanwood, G.D.3
Winder, D.G.4
-
29
-
-
71749097066
-
5
-
5 Bioorg. Med. Chem. Lett. 19, 6623-6626
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 6623-6626
-
-
Felts, A.S.1
Saleh, S.A.2
Le, U.3
Rodriguez, A.L.4
Weaver, C.D.5
Conn, P.J.6
Lindsley, C.W.7
Emmitte, K.A.8
-
30
-
-
71749106942
-
Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS
-
Zhou, Y., Rodriguez, A. L., Williams, R., Weaver, C. D., Conn, P. J., and Lindsley, C. W. (2009) Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS Bioorg. Med. Chem. Lett. 19, 6502-6506
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 6502-6506
-
-
Zhou, Y.1
Rodriguez, A.L.2
Williams, R.3
Weaver, C.D.4
Conn, P.J.5
Lindsley, C.W.6
-
31
-
-
65749112588
-
Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype
-
Rodriguez, A. L., Williams, R., Zhou, Y., Lindsley, S. R., Le, U., Grier, M. D., Weaver, C. D., Conn, P. J., and Lindsley, C. W. (2009) Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype Bioorg. Med. Chem. Lett. 19, 3209-3213
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 3209-3213
-
-
Rodriguez, A.L.1
Williams, R.2
Zhou, Y.3
Lindsley, S.R.4
Le, U.5
Grier, M.D.6
Weaver, C.D.7
Conn, P.J.8
Lindsley, C.W.9
-
32
-
-
79953171633
-
5 NAMs, PAMs and partial antagonists
-
5 NAMs, PAMs and partial antagonists Bioorg. Med. Chem. Lett. 21, 2711-2714
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 2711-2714
-
-
Lamb, J.P.1
Engers, D.W.2
Niswender, C.M.3
Rodriguez, A.L.4
Venable, D.F.5
Conn, P.J.6
Conn, P.J.7
-
33
-
-
84971012261
-
5: Discovery of a new tool compound with activity in the OSS mouse model of addiction
-
5: Discovery of a new tool compound with activity in the OSS mouse model of addiction ACS Chem. Neurosci. 2, 471-482
-
(2011)
ACS Chem. Neurosci.
, vol.2
, pp. 471-482
-
-
Lindsley, C.W.1
Bates, B.S.2
Menon, U.N.3
Jadhav, S.B.4
Kane, A.S.5
Jones, C.K.6
Rodriguez, A.L.7
Conn, P.J.8
Olsen, C.M.9
Winder, D.G.10
Emmitte, K.A.11
-
34
-
-
77955415857
-
5: Identification of easily prepared tool compounds with CNS exposure in rats
-
5: Identification of easily prepared tool compounds with CNS exposure in rats Bioorg. Med. Chem. Lett. 20, 4390-4394
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 4390-4394
-
-
Felts, A.S.1
Lindsley, S.R.2
Lamb, J.P.3
Rodriguez, A.L.4
Menon, U.N.5
Jadhav, S.6
Jones, C.K.7
Conn, P.J.8
Lindsley, C.W.9
Emmitte, K.A.10
-
35
-
-
84857732011
-
5): From an artificial neural network virtual screen to an in vivo tool compound
-
5): From an artificial neural network virtual screen to an in vivo tool compound ChemMedChem 7, 406-414
-
(2012)
ChemMedChem
, vol.7
, pp. 406-414
-
-
Mueller, R.1
Dawson, E.S.2
Meiler, J.3
Rodriguez, A.L.4
Chauder, B.A.5
Bates, B.S.6
Felts, A.S.7
Lamb, J.P.8
Menon, U.N.9
Jadhav, S.B.10
Kane, A.S.11
Jones, C.K.12
Gregory, K.J.13
Niswender, C.M.14
Conn, P.J.15
Olsen, C.M.16
Winder, D.G.17
Emmitte, K.A.18
Lindsley, C.W.19
-
36
-
-
47149106805
-
Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: Unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold
-
Sharma, S., Rodriguez, A. L., Conn, P. J., and Lindsley, C. W. (2008) Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: Unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold Bioorg. Med. Chem. Lett. 18, 4098-4101
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4098-4101
-
-
Sharma, S.1
Rodriguez, A.L.2
Conn, P.J.3
Lindsley, C.W.4
-
37
-
-
27844482134
-
A close structural analogue of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effect of multiple allosteric modulators
-
Rodriguez, A. L., Nong, Y., Sekaran, N. K., Alagille, D., Tamagnan, G. D., and Conn, P. J. (2005) A close structural analogue of 2-methyl-6- (phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effect of multiple allosteric modulators Mol. Pharmacol. 68, 1793-1802
-
(2005)
Mol. Pharmacol.
, vol.68
, pp. 1793-1802
-
-
Rodriguez, A.L.1
Nong, Y.2
Sekaran, N.K.3
Alagille, D.4
Tamagnan, G.D.5
Conn, P.J.6
-
38
-
-
84867865129
-
Discovery and characterization of AZD9272 and AZD6538 - Two novel mGluR5 negative allosteric modulators selected for clinical development
-
Raboisson, P., Breitholtz-Emanuelsson, A., Dahllöf, H., Edwards, L., Heaton, W. L., Isaac, M., Jarvie, K., Kers, A., Minidis, A. B. E., Nordmark, A., Sheehan, S. M., Slassi, A., Ström, P., Terelius, Y., Wensbo, D., Wilson, J. M., Xin, T., and McLeod, D. A. (2012) Discovery and characterization of AZD9272 and AZD6538-Two novel mGluR5 negative allosteric modulators selected for clinical development Bioorg. Med. Chem. Lett. 22, 6974-6979
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 6974-6979
-
-
Raboisson, P.1
Breitholtz-Emanuelsson, A.2
Dahllöf, H.3
Edwards, L.4
Heaton, W.L.5
Isaac, M.6
Jarvie, K.7
Kers, A.8
Minidis, A.B.E.9
Nordmark, A.10
Sheehan, S.M.11
Slassi, A.12
Ström, P.13
Terelius, Y.14
Wensbo, D.15
Wilson, J.M.16
Xin, T.17
McLeod, D.A.18
-
39
-
-
66749109859
-
Structure-activity relationships comparing N -(6-methylpyridin-yl)- substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists
-
Kulkarni, S. S., Zou, M.-F., Cao, J., Deschamps, J. R., Rodriguez, A. L., Conn, P. J., and Newman, A. H. (2009) Structure-activity relationships comparing N -(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted- arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists J. Med. Chem. 52, 3563-3575
-
(2009)
J. Med. Chem.
, vol.52
, pp. 3563-3575
-
-
Kulkarni, S.S.1
Zou, M.-F.2
Cao, J.3
Deschamps, J.R.4
Rodriguez, A.L.5
Conn, P.J.6
Newman, A.H.7
-
40
-
-
34447340637
-
Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists
-
Milbank, J. B. J., Knauer, C. S., Augelli-Szafran, C. E., Sakkab-Tan, A. T., Lin, K. K., Yamagata, K., Hoffman, J. K., Zhuang, N., Thomas, J., Galatsis, P., Wendt, J. A., Mickelson, J. W., Schwarz, R. D., Kinsora, J. J., Lotarski, S. M., Stakich, K., Gillespie, K. K., Lam, W. W., and Mutlib, A. E. (2007) Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists Bioorg. Med. Chem. Lett. 17, 4415-4418
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 4415-4418
-
-
Milbank, J.B.J.1
Knauer, C.S.2
Augelli-Szafran, C.E.3
Sakkab-Tan, A.T.4
Lin, K.K.5
Yamagata, K.6
Hoffman, J.K.7
Zhuang, N.8
Thomas, J.9
Galatsis, P.10
Wendt, J.A.11
Mickelson, J.W.12
Schwarz, R.D.13
Kinsora, J.J.14
Lotarski, S.M.15
Stakich, K.16
Gillespie, K.K.17
Lam, W.W.18
Mutlib, A.E.19
-
41
-
-
25844475955
-
3-[Substituted]-5-(5-pyridin-2-yl-2 H -tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists
-
Tehrani, L. R., Smith, N. D., Huang, D., Poon, S. F., Roppe, J. R., Seiders, T. J., Chapman, D. F., Chung, J., Cramer, M., and Cosford, N. D. P. (2005) 3-[Substituted]-5-(5-pyridin-2-yl-2 H -tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists Bioorg. Med. Chem. Lett. 15, 5061-5064
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 5061-5064
-
-
Tehrani, L.R.1
Smith, N.D.2
Huang, D.3
Poon, S.F.4
Roppe, J.R.5
Seiders, T.J.6
Chapman, D.F.7
Chung, J.8
Cramer, M.9
Cosford, N.D.P.10
-
42
-
-
20844455452
-
Synthesis, characterization, and first successful monkey imaging studies of metabotropic monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers
-
Hamill, T. G., Krause, S., Ryan, C., Bonnefous, C., Govek, S., Seiders, T. J., Cosford, N. D. P., Roppe, J., Kamenecka, T., Patel, S., Gibson, R. E., Sanabria, S., Riffel, K., Eng, W., King, C., Yang, X., Green, M. D., O'Malley, S. S., Hargreaves, R., and Burns, H. D. (2005) Synthesis, characterization, and first successful monkey imaging studies of metabotropic monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers Synapse 56, 205-216
-
(2005)
Synapse
, vol.56
, pp. 205-216
-
-
Hamill, T.G.1
Krause, S.2
Ryan, C.3
Bonnefous, C.4
Govek, S.5
Seiders, T.J.6
Cosford, N.D.P.7
Roppe, J.8
Kamenecka, T.9
Patel, S.10
Gibson, R.E.11
Sanabria, S.12
Riffel, K.13
Eng, W.14
King, C.15
Yang, X.16
Green, M.D.17
O'Malley, S.S.18
Hargreaves, R.19
Burns, H.D.20
more..
-
43
-
-
0036874825
-
Influence of non-specific brain and plasma binding on CNS exposure: Implications for rational drug discovery
-
Kalvass, J. C. and Maurer, T. S. (2002) Influence of non-specific brain and plasma binding on CNS exposure: implications for rational drug discovery Biopharm. Drug Dispos. 23, 327-338
-
(2002)
Biopharm. Drug Dispos.
, vol.23
, pp. 327-338
-
-
Kalvass, J.C.1
Maurer, T.S.2
-
44
-
-
84861570191
-
5 PAM
-
5 PAM Bioorg. Med. Chem. Lett. 22, 3921-3925
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 3921-3925
-
-
Sheffler, D.J.1
Wenthur, C.J.2
Bruner, J.A.3
Carrington, S.J.S.4
Vinson, P.J.5
Gogi, K.K.6
Blobaum, A.L.7
Morrison, R.M.8
Vamos, M.9
Cosford, N.D.S.10
Stauffer, S.R.11
Daniels, J.S.12
Niswender, C.M.13
Conn, P.J.14
Lindsley, C.W.15
-
45
-
-
84856022448
-
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease
-
Jones, C. K., Bubser, M., Thompson, A. D., Dickerson, J. W., Turle-Lorenzo, N., Amalric, M., Blobaum, A. L., Bridges, T. M., Morrison, R. D., Jadhav, S., Engers, D. W., Italiano, K., Bode, J., Daniels, J. S., Lindsley, C. W., Hopkins, C. W., Conn, P. J., and Niswender, C. M. (2012) The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease J. Pharmacol. Exp. Ther. 340, 404-421
-
(2012)
J. Pharmacol. Exp. Ther.
, vol.340
, pp. 404-421
-
-
Jones, C.K.1
Bubser, M.2
Thompson, A.D.3
Dickerson, J.W.4
Turle-Lorenzo, N.5
Amalric, M.6
Blobaum, A.L.7
Bridges, T.M.8
Morrison, R.D.9
Jadhav, S.10
Engers, D.W.11
Italiano, K.12
Bode, J.13
Daniels, J.S.14
Lindsley, C.W.15
Hopkins, C.W.16
Conn, P.J.17
Niswender, C.M.18
-
46
-
-
77149174796
-
Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7
-
Niswender, C. M., Johnson, K. A., Miller, N. R., Ayala, J. E., Luo, Q., Williams, R., Saleh, S., Orton, D., Weaver, C. D., and Conn, P. J. (2010) Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7 Mol. Pharmacol. 77, 459-468
-
(2010)
Mol. Pharmacol.
, vol.77
, pp. 459-468
-
-
Niswender, C.M.1
Johnson, K.A.2
Miller, N.R.3
Ayala, J.E.4
Luo, Q.5
Williams, R.6
Saleh, S.7
Orton, D.8
Weaver, C.D.9
Conn, P.J.10
-
47
-
-
84883236812
-
-
LeadProfilingScreen, Eurofins Panlabs, Inc.
-
LeadProfilingScreen, Eurofins Panlabs, Inc. (http://www.eurofinspanlabs. com).
-
-
-
-
48
-
-
84878238320
-
Prefrontal synaptic markers of cocaine addiction-like behavior in rats
-
Kasanetz, F., Lafourcade, M., Deroche-Gamonet, V., Revest, J.-M., Berson, N., Balado, E., Fiancette, J.-F., Renault, P., Piazza, P.-V., and Manzoni, O. J. (2013) Prefrontal synaptic markers of cocaine addiction-like behavior in rats Mol. Psychiatry 18, 729-737
-
(2013)
Mol. Psychiatry
, vol.18
, pp. 729-737
-
-
Kasanetz, F.1
Lafourcade, M.2
Deroche-Gamonet, V.3
Revest, J.-M.4
Berson, N.5
Balado, E.6
Fiancette, J.-F.7
Renault, P.8
Piazza, P.-V.9
Manzoni, O.J.10
-
49
-
-
17644374100
-
The neural basis of addiction: A pathology of motivation and choice
-
Kalivas, P. W. and Volkow, N. D. (2005) The neural basis of addiction: a pathology of motivation and choice Am. J. Psychiatry 162, 1403-1413
-
(2005)
Am. J. Psychiatry
, vol.162
, pp. 1403-1413
-
-
Kalivas, P.W.1
Volkow, N.D.2
-
50
-
-
0242352382
-
Amygdalar control of the mesocorticolimbic dopamine system: Parallel pathways to motivated behavior
-
Phillips, A. G., Ahn, S., and Howland, J. G. (2003) Amygdalar control of the mesocorticolimbic dopamine system: parallel pathways to motivated behavior Neurosci. Biobehav. Rev. 27, 543-554
-
(2003)
Neurosci. Biobehav. Rev.
, vol.27
, pp. 543-554
-
-
Phillips, A.G.1
Ahn, S.2
Howland, J.G.3
-
51
-
-
0037276699
-
Appetitive behavior: Impact of amygdala-dependent mechanisms of emotional learning
-
Everitt, B. J., Cardinal, R. N., Parkinson, J. A., and Robbins, T. W. (2003) Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning Ann. N.Y. Acad. Sci. 985, 233-250
-
(2003)
Ann. N.Y. Acad. Sci.
, vol.985
, pp. 233-250
-
-
Everitt, B.J.1
Cardinal, R.N.2
Parkinson, J.A.3
Robbins, T.W.4
-
52
-
-
0032104560
-
Drug-activation of brain reward pathways
-
Wise, R. A. (1998) Drug-activation of brain reward pathways Drug Alcohol Depend. 51, 13-22
-
(1998)
Drug Alcohol Depend.
, vol.51
, pp. 13-22
-
-
Wise, R.A.1
-
53
-
-
80054967020
-
Advances in animal models of drug addiction
-
Heidbreder, C. (2011) Advances in animal models of drug addiction Curr. Top. Behav. Neurosci. 7, 213-250
-
(2011)
Curr. Top. Behav. Neurosci.
, vol.7
, pp. 213-250
-
-
Heidbreder, C.1
-
54
-
-
34547610708
-
Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade
-
Tzschentke, T. M. (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade Addict. Biol. 12, 227-462
-
(2007)
Addict. Biol.
, vol.12
, pp. 227-462
-
-
Tzschentke, T.M.1
-
55
-
-
78649948724
-
The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats
-
Rutten, K., van der Kam, E. L., De Vry, J., Bruckman, W., and Tzschentke, T. M. (2011) The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats Addict. Biol. 16, 108-115
-
(2011)
Addict. Biol.
, vol.16
, pp. 108-115
-
-
Rutten, K.1
Van Der Kam, E.L.2
De Vry, J.3
Bruckman, W.4
Tzschentke, T.M.5
-
56
-
-
62549140970
-
5 receptor antagonist 2-methyl-6-(phenylethynyl) pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat
-
5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat Eur. J. Pharmacol. 607, 114-120
-
(2009)
Eur. J. Pharmacol.
, vol.607
, pp. 114-120
-
-
Van Der Kam, E.L.1
De Vry, J.2
Tzschentke, T.M.3
-
57
-
-
44449088516
-
Chronic intravenous drug self-administration in rats and mice
-
chapter 9, unit 9.20.
-
Thomsen, M. and Caine, S. B. (2005) Chronic intravenous drug self-administration in rats and mice. Curr. Protoc. Neurosci. chapter 9, unit 9.20.
-
(2005)
Curr. Protoc. Neurosci.
-
-
Thomsen, M.1
Caine, S.B.2
-
58
-
-
84863999446
-
Conditioned Place Preference
-
In (Buccafusco, J. J. Ed.), 2 nd ed. CRC Press, Boca Raton, FL.
-
Prus, A. J., James, J. R., and Rosecrans, J. A. (2009) Conditioned Place Preference. In Methods of Behavior Analysis in Neuroscience (Buccafusco, J. J., Ed.), 2 nd ed., CRC Press, Boca Raton, FL.
-
(2009)
Methods of Behavior Analysis in Neuroscience
-
-
Prus, A.J.1
James, J.R.2
Rosecrans, J.A.3
|